| 朝陽科技大學 |
2011 |
Eventually Byzantine Agreement on CDS-based mobile ad hoc network
|
江茂綸 |
| 朝陽科技大學 |
2003 |
Eventually Dual Failure Agreement
|
王淑卿; 鄭建富; Wang, Shu-Ching; Cheng, C.F. |
| 淡江大學 |
2011-05-13 |
Ever After: A Modern Cinderella Romance
|
Shih, Yi-chin |
| 國家衛生研究院 |
2005-12 |
Ever having suicide ideation among the 4th graders in northern Taiwan and its correlates
|
Chiang, Y;Wu, S;Yen, L |
| 臺大學術典藏 |
2021-08-05T02:39:37Z |
Everlasting Living and Breathing Gyroid 3D Network in Si@SiOx/C Nanoarchitecture for Lithium Ion Battery
|
Lee J;Moon J;Han S.A;Kim J;Malgras V;Heo Y.-U;Kim H;Lee S.-M;Liu H.K;Dou S.X;Yamauchi Y;Park M.-S;Kim J.H.; Lee J; KEVIN CHIA-WEN WU et al. |
| 修平科技大學 |
2016-05 |
EverMind
|
張雅婷;薛翊辰;蔡宇捷;石金鑫;葉子琳 |
| 國立臺灣科技大學 |
2000 |
EverNet全球資訊網之開發
|
卓政宏;李漢銘 |
| 臺大學術典藏 |
2018-09-10T09:42:02Z |
Everolimus for previously treated advanced gastric cancer: Results of the randomized, double-blind, phase III GRANITE-1 study
|
Ohtsu, A. and Ajani, J.A. and Bai, Y.-X. and Bang, Y.-J. and Chung, H.-C. and Pan, H.-M. and Sahmoud, T. and Shen, L. and Yeh, K.-H. and Chin, K. and Muro, K. and Kim, Y.H. and Ferry, D. and Tebbutt, N.C. and Al-Batran, S.-E. and Smith, H. and Costantini, C. and Rizvi, S. and Lebwohl, D. and Van Cutsem, E.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:36Z |
Everolimus for previously treated advanced gastric cancer: Results of the randomized, double-blind, phase III GRANITE-1 study
|
Ohtsu A.;Ajani J.A.;Bai Y.-X.;Bang Y.-J.;Chung H.-C.;Pan H.-M.;Sahmoud T.;Shen L.;Kun-Huei Yeh;Chin K.;Muro K.;Kim Y.H.;Ferry D.;Tebbutt N.C.;Al-Batran S.-E.;Smith H.;Costantini C.;Rizvi S.;Lebwohl D.;Van Cutsem E.; Ohtsu A.; Ajani J.A.; Bai Y.-X.; Bang Y.-J.; Chung H.-C.; Pan H.-M.; Sahmoud T.; Shen L.; KUN-HUEI YEH; Chin K.; Muro K.; Kim Y.H.; Ferry D.; Tebbutt N.C.; Al-Batran S.-E.; Smith H.; Costantini C.; Rizvi S.; Lebwohl D.; Van Cutsem E. |
| 國立臺灣大學 |
2013 |
Everolimus immunosuppression in de novo heart transplant recipients: What does the evidence tell us now?
|
Zuckermann, Andreas; Wang, Shoei-Shen; Epailly, Eric; Barten, Markus J.; Sigurdardottir, Vilborg; Segovia, Javier; Varnous, Shaida; Turazza, Fabio M.; Potena, Luciano; Lehmkuhl, Hans B.; 王水深 |
| 臺大學術典藏 |
2018-09-10T09:52:17Z |
Everolimus immunosuppression in de novo heart transplant recipients: What does the evidence tell us now?
|
Zuckermann, A.;Wang, S.-S.;Epailly, E.;Barten, M.J.;Sigurdardottir, V.;Segovia, J.;Varnous, S.;Turazza, F.M.;Potena, L.;Lehmkuhl, H.B.; Zuckermann, A.; Wang, S.-S.; Epailly, E.; Barten, M.J.; Sigurdardottir, V.; Segovia, J.; Varnous, S.; Turazza, F.M.; Potena, L.; Lehmkuhl, H.B. |
| 臺大學術典藏 |
2020-03-05T08:37:43Z |
Everolimus immunosuppression in de novo heart transplant recipients: What does the evidence tell us now?
|
Zuckermann A.; SHOEI-SHEN WANG; Epailly E.; Barten M.J.; Sigurdardottir V.; Segovia J.; Varnous S.; Turazza F.M.; Potena L.; Lehmkuhl H.B. |
| 國立臺灣大學 |
2007 |
Everolimus in De Novo Heart Transplant Recipients: Six Month Data on Cyclosporine Reduction and Impact on Renal Function
|
王水深; WANG, SHOEI-SHEN |
| 國立臺灣大學 |
2013 |
Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation
|
Kobashigawa, J.; Ross, H.; Bara, C.; Delgado, J. F.; Dengler, T.; Lehmkuhl, H. B.; Wang, S. -S.; Dong, G.; Witte, S.; Junge, G.; Potena, L.; 王水深 |
| 臺大學術典藏 |
2018-09-10T09:52:17Z |
Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation
|
Ross, H.; Bara, C.; Delgado, J.F.; Dengler, T.; Lehmkuhl, H.B.; Wang, S.-S.; Dong, G.; Witte, S.; Junge, G.; Potena, L.; Kobashigawa, J. |
| 臺大學術典藏 |
2020-03-05T08:37:44Z |
Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation
|
Kobashigawa J.;Ross H.;Bara C.;Delgado J.F.;Dengler T.;Lehmkuhl H.B.;Shoei-Shen Wang;Dong G.;Witte S.;Junge G.;Potena L.; Kobashigawa J.; Ross H.; Bara C.; Delgado J.F.; Dengler T.; Lehmkuhl H.B.; SHOEI-SHEN WANG; Dong G.; Witte S.; Junge G.; Potena L. |
| 臺大學術典藏 |
2020-12-18T02:21:40Z |
Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures
|
Yang M.-T.;Lin Y.-C.;Ho W.-H.;Liu C.-L.;Wang-Tso Lee; Yang M.-T.; Lin Y.-C.; Ho W.-H.; Liu C.-L.; WANG-TSO LEE |
| 臺大學術典藏 |
2018-09-10T09:52:17Z |
Everolimus versus mycophenolate mofetil in heart transplantation: A randomized, multicenter trial
|
Kobashigawa, J.; Starling, R.C.; Pauly, D.F.; Kfoury, A.; Ross, H.; Wang, S.-S.; Cantin, B.; Van Bakel, A.; Ewald, G.; Hirt, S.; Lehmkuhl, H.; Keogh, A.; Rinaldi, M.; Potena, L.; Zuckermann, A.; Dong, G.; Cornu-Artis, C.; Lopez, P.; Eisen, H.J. |
| 臺大學術典藏 |
2020-03-05T08:37:43Z |
Everolimus versus mycophenolate mofetil in heart transplantation: A randomized, multicenter trial
|
Eisen H.J.;Kobashigawa J.;Starling R.C.;Pauly D.F.;Kfoury A.;Ross H.;Shoei-Shen Wang;Cantin B.;Van Bakel A.;Ewald G.;Hirt S.;Lehmkuhl H.;Keogh A.;Rinaldi M.;Potena L.;Zuckermann A.;Dong G.;Cornu-Artis C.;Lopez P.; Eisen H.J.; Kobashigawa J.; Starling R.C.; Pauly D.F.; Kfoury A.; Ross H.; SHOEI-SHEN WANG; Cantin B.; Van Bakel A.; Ewald G.; Hirt S.; Lehmkuhl H.; Keogh A.; Rinaldi M.; Potena L.; Zuckermann A.; Dong G.; Cornu-Artis C.; Lopez P. |
| 臺大學術典藏 |
2020-12-02T11:04:32Z |
Everolimus-eluting bioresorbable vascular scaffold in real world practice - A single center experience
|
Liang H.-W.; Kao H.-L.; Lin Y.-H.; Hwang J.-J.; Lin M.-S.; Chiang F.-T.; Lee C.-M.; Yeh C.-F.; Wang T.-D.; CHO-KAI WU; Lin L.-Y.; Tsai C.-T.; Chen Y.-H. |
| 臺大學術典藏 |
2020-12-04T04:19:00Z |
Everolimus-eluting bioresorbable vascular scaffold in real world practice - A single center experience
|
Liang H.-W.; Kao H.-L.; Lin Y.-H.; Hwang J.-J.; Lin M.-S.; Chiang F.-T.; CHII-MING LEE; Yeh C.-F.; Wang T.-D.; Wu C.-K.; Lin L.-Y.; Tsai C.-T.; Chen Y.-H. |
| 臺大學術典藏 |
2020-12-25T08:38:37Z |
Everolimus-eluting bioresorbable vascular scaffold in real world practice - A single center experience
|
Yeh C.-F.; Wang T.-D.; Wu C.-K.; Lin L.-Y.; Tsai C.-T.; Chen Y.-H.; Liang H.-W.; HSIEN-LI KAO; Lin Y.-H.; Hwang J.-J.; Lin M.-S.; Chiang F.-T.; Lee C.-M. |
| 臺大學術典藏 |
2020-12-28T09:31:18Z |
Everolimus-eluting bioresorbable vascular scaffold in real world practice - A single center experience
|
Yeh C.-F.; Lee C.-M.; Chiang F.-T.; Lin M.-S.; Hwang J.-J.; Lin Y.-H.; Kao H.-L.; Liang H.-W.; Wang T.-D.; Wu C.-K.; Lin L.-Y.; Tsai C.-T.; YING-HSIEN CHEN |
| 臺大學術典藏 |
2020-12-28T12:03:51Z |
Everolimus-eluting bioresorbable vascular scaffold in real world practice - A single center experience
|
Chen Y.-H.; Tsai C.-T.; Lin L.-Y.; Wu C.-K.; Lee C.-M.; Yeh C.-F.; Wang T.-D.; Chiang F.-T.; Lin M.-S.; HWANG, JUEY-JEN; Lin Y.-H.; Kao H.-L.; Liang H.-W. |
| 臺大學術典藏 |
2021-03-11T04:29:29Z |
Everolimus-eluting bioresorbable vascular scaffold in real world practice - A single center experience
|
Liang H.-W.;Kao H.-L.;Lin Y.-H.;Hwang J.-J.;Lin M.-S.;Fu-Tien Chiang;Lee C.-M.;Yeh C.-F.;Wang T.-D.;Wu C.-K.;Lin L.-Y.;Tsai C.-T.;Chen Y.-H.; Liang H.-W.; Kao H.-L.; Lin Y.-H.; Hwang J.-J.; Lin M.-S.; FU-TIEN CHIANG; Lee C.-M.; Yeh C.-F.; Wang T.-D.; Wu C.-K.; Lin L.-Y.; Tsai C.-T.; Chen Y.-H. |
